The group in Canada has extensively studied the factors (known as biomarkers) that can influence how people respond to anti-psychotic drugs, including if patients will develop side-effects. Our group in Liverpool has experience with compiling and analysing the large amounts of evidence required to prove a link between the biomarkers, and the patient’s response. The […]
Read More